[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

  • Biotechnology
  • Chemicals
  • Food processing
  • Electronics
  • Healthcare
  • Pharmaceuticals


Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

  • Market segmentation
  • Competitive landscape
  • Regulatory policies
  • Latest technology trends
  • Acquisition evaluations
  • Vendors’ analysis, etc.
Publications found: 55,899
Sort by:

2014-2018 World Animal Health Market Dynamics, Trends and Leading Suppliers' Strategies, Marketing Tactics, and Technological Know-How

US$ 3,880.00

... provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for: Major market segments Key geographic regions ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion ...

November 2014 110 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. ...

November 2014 280 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Banking Instrumentation, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, ...

November 2014 111 pages

2014-2018 Analysis of Molecular and Immunohematology Blood Banking Technologies, and Strategic Profiles of Leading Suppliers

US$ 3,080.00

This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...

November 2014 154 pages

Future Horizons and Growth Strategies in the Alpha-2 Antiplasmin Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 195 pages and 8 tables

August 2014 195 pages

Future Horizons and Growth Strategies in the Antithrombin III Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 197 pages and 8 tables

August 2014 197 pages

Future Horizons and Growth Strategies in the D-Dimer Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 197 pages and 8 tables

August 2014 197 pages

Future Horizons and Growth Strategies in the Factor Assay Testing Market 2014: Country Forecasts

US$ 4,280.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 295 pages and 85 tables

August 2014 295 pages

Future Horizons and Growth Strategies in the Fibrinogen Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Heparin Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Proteins C and S Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 194 pages and 15 tables

August 2014 194 pages

Future Horizons and Growth Strategies in the PT Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 200 pages and 8 tables

August 2014 200 pages

Future Horizons and Growth Strategies in the Thrombin Time Testing Market 2014: Country Forecasts

US$ 3,480.00

... other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks. Contains 196 pages and 8 tables

August 2014 196 pages

Future Horizons and Growth Strategies in the US Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 2,800.00

This new 236-page report from Venture Planning Group provides analysis of the US immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the French Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the French immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the German Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the Italian Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 233-page report from Venture Planning Group provides analysis of the Italian immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 233 pages

Future Horizons and Growth Strategies in the Japanese Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 2,200.00

This new 234-page report from Venture Planning Group provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the Spanish Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the Spanish immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 236 pages

Future Horizons and Growth Strategies in the UK Immunoprotein Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

August 2014 234 pages

Future Horizons and Growth Strategies in the Home/Self Testing Market 2014

US$ 1,160.00

... new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.

August 2014 175 pages

Future Horizons and Growth Strategies in the US Home/Self Testing Market 2014

US$ 1,160.00

... new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.

August 2014 175 pages

2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers

US$ 276,000.00

... has published a series of 10 global market research surveys, “2014 World In Vitro Diagnostics Industry:Market Shares and Country Forecasts.” ... Beckman Coulter/Danaher Becton Dickinson Bio/Data Biokit Biomedical Diagnostics Biomerieux Bio-Rad Biotest Caliper Cellavision Cephid Chrono-Log ...

August 2014 9700 pages

Analogic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 49 pages

Esaote: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 33 pages

GE: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 127 pages

Hitachi: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

The strategic assessment of Hitachi, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

August 2014 107 pages

Hologic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 49 pages

Philips: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 133 pages

Shimadzu: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

The strategic assessment of Shimadzu, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

August 2014 65 pages

Siemens: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

August 2014 111 pages

Toshiba: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector

US$ 1,960.00

The strategic assessment of Toshiba, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

August 2014 116 pages

Zimmer: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Programs Section 7: Strategic Direction Contains 30 ...

July 2014 30 pages

Wright Medical: Organization, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...

July 2014 30 pages

Stryker: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Expenditures and Major Programs Section 7: ...

July 2014 35 pages

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 27,600.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

July 2014 1200 pages

2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 15,760.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

July 2014 820 pages

2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. French Market Overview Five-year test volume and sales ...

July 2014 585 pages

2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices

US$ 5,360.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. German Market Overview Five-year test volume and sales ...

July 2014 585 pages

2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Italian Market Overview Five-year test volume and sales ...

July 2014 570 pages

2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 7,040.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Japanese Market Overview Five-year test volume and sales ...

July 2014 590 pages

2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

July 2014 565 pages

2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

July 2014 565 pages

2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 7,840.00

... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...

July 2014 620 pages

Smith & Nephew: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...

July 2014 37 pages

Medtronic: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: Research & Development Section 7: Strategic Direction ...

July 2014 25 pages

DePuy Synthes: Organization, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... , capabilities, goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: Research & Development Section 6: Strategic Direction Contains 46 ...

July 2014 46 pages

ConMed: Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Facilities and Employees Section 3: Technological Know-how Section 4: Product Portfolio Section 5: Marketing Tactics Section 6: R&D Programs Section 7: Strategic Direction Contains ...

July 2014 25 pages

Biomet: Organization, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... , goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: R&D Expenditures and Major Programs Section 6: Strategic Direction Contains 35 ...

July 2014 35 pages

Aesculap: Organization, Technologies, Products, Marketing, R&D, Strategies

US$ 1,480.00

... , capabilities, goals and strategies in the global orthopedics market. Table of Contents Section 1: Business Evolution and Organization Section 2: Technological Know-how Section 3: Product Portfolio Section 4: Marketing Tactics Section 5: R&D Programs Section 6: Strategic Direction Contains 22 pages

July 2014 22 pages

Filters

Search

Categories

3
6
274
2
181
177
55
791
640
521
450
393
313
216
877
245
242
201
65
33
17
17
15
14
10
8
7
5
4
3
2
2
2
1
1
2
5
1,403
45
603
33,410
43
8
15
2
1,389
1,108
252
1,228
146
97
1
69
3
53
631
6
932
21
6
1
253
3,934
324
1
644
585
228
219
202
97
69
35
17
15
813
27
344
88
11
1
1
591
20
108

Publishers

55,899

Regions

16
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
175
194
193
15
104
194
5
174
197
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
192
192
192
192
192
191
191
191
137
137
4
3
2
201
201
198
198
198
197
197
197
197
196
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
191
191
190
188
187
110
107
107
106
106
1,152
201
197
29,126
1,621
1,267
1,265
1,261
1,245
1,236
1,210
401
200

Price

Date

Pages

Offers